Carnegie 437, 600 N. Wolfe St.
Baltimore, MD 21287
United States of America
Dr. Tobian is a physician-scientist at Johns Hopkins University and Director of Transfusion Medicine at Johns Hopkins Hospital. Dr. Tobian and his research group focus on improving the understanding HIV and other transfusion transmitted infections to develop innovative interventions for improved prevention. Over the past 15 years, Dr. Tobian has lived or worked in five developing countries. Most of his projects involve large international multi-country studies, including a recently completed study with reporting requirements to a Technical Advisory Group consisting of members from USAID, PEPFAR, CDC, Department of Defense, WHO, and UNICEF. Dr. Tobian and his colleagues have shown male circumcision reduces the risk of HIV, herpes simplex virus type-2 (HSV-2), high-risk human papillomavirus (HR-HPV), and proinflammatory anaerobes in the penile microbiome in heterosexual men. They have also found that male circumcision decreases HR-HPV transmission to female partners. His work showed that male circumcision is cost-effective and is the single best one-time intervention to reduce HIV and other sexually transmitted infections. These collective data led the American Academy of Pediatrics to change their guidelines to support male circumcision. Dr. Tobian and his research group are currently studying whether HIV-infected renal and liver allografts can be safely transplanted into HIV-infected recipients. In addition, Dr. Tobian is the Principal Investigator of a 2,000 person randomized trial to assess whether pathogen reduction technology can reduce transfusion transmitted infections in Uganda. Dr. Tobian also serves as Vice Chair for Clinical Affairs for the Department of Pathology at Johns Hopkins University.
Johns Hopkins University School of Medicine (Primary)
Stuart C. Ray, MD is the representative at this institution.